clever leaves, a colombian company fully-licensed, will become the world’s largest grower with over 10mm+ ft2 of cultivation capacity by 2023, the largest extractor with pharmaceutical grade and gmp certified processing facilities, and the lowest cost operator in cannabis exports. one of the first colombian license holders in the medical cannabis industry. a company positioned to become a leader in the global market with a differentiated business model and strong positioning with regulators, physicians, and other relevant players. developing key capabilities to win in the new space of the medical cannabis industry with a highly experienced and respected team.
Company profile
Ticker
CLVR
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Clever Leaves US, Inc. • NS US Holdings, Inc. • Herbal Brands, Inc. • 1255096 B.C. Ltd. • Northern Swan International, Inc. • Northern Swan Management, Inc. • Clever Leaves Australia Pvt Ltd • Northern Swan Deutschland Holdings, Inc. • Northern Swan Portugal Holdings, Inc. • Clever Leaves II Portugal Cultivation SA ...
CLVR stock data
Latest filings (excl ownership)
8-K
Clever Leaves Announces Voluntary Delisting and SEC Deregistration
26 Apr 24
EFFECT
Notice of effectiveness
23 Apr 24
AW
Withdrawal of amendment
18 Apr 24
8-K
Termination of a Material Definitive Agreement
17 Apr 24
POS AM
Prospectus update (post-effective amendment)
16 Apr 24
S-3/A
Shelf registration (amended)
15 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
8-K
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
1 Apr 24
424B3
Prospectus supplement
27 Mar 24
8-K
Entry into a Material Definitive Agreement
27 Mar 24
Transcripts
CLVR
Earnings call transcript
2023 Q3
9 Nov 23
CLVR
Earnings call transcript
2023 Q2
14 Aug 23
CLVR
Earnings call transcript
2023 Q1
11 May 23
CLVR
Earnings call transcript
2022 Q4
31 Mar 23
CLVR
Earnings call transcript
2022 Q3
10 Nov 22
CLVR
Earnings call transcript
2022 Q2
12 Aug 22
CLVR
Earnings call transcript
2022 Q1
13 May 22
CLVR
Earnings call transcript
2021 Q4
25 Mar 22
CLVR
Earnings call transcript
2021 Q3
11 Nov 21
CLVR
Earnings call transcript
2021 Q2
13 Aug 21
Latest ownership filings
4
Henry R Hague III
12 Mar 24
4
Henry R Hague III
29 Feb 24
4
Julian Wilches
23 Jan 24
4
Andres Fajardo
23 Jan 24
SC 13G/A
FARALLON CAPITAL MANAGEMENT LLC
23 Jan 24
4/A
Andres Fajardo
22 Dec 23
4/A
Julian Wilches
22 Dec 23
4
Julian Wilches
21 Dec 23
4
Andres Fajardo
21 Dec 23
4
Julian Wilches
19 Jul 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.54 mm | 6.54 mm | 6.54 mm | 6.54 mm | 6.54 mm | 6.54 mm |
Cash burn (monthly) | (no burn) | 922.42 k | 1.13 mm | 3.87 mm | 733.67 k | 1.26 mm |
Cash used (since last report) | n/a | 6.37 mm | 7.77 mm | 26.69 mm | 5.07 mm | 8.67 mm |
Cash remaining | n/a | 169.63 k | -1.23 mm | -20.15 mm | 1.47 mm | -2.13 mm |
Runway (months of cash) | n/a | 0.2 | -1.1 | -5.2 | 2.0 | -1.7 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 11 |
Opened positions | 7 |
Closed positions | 31 |
Increased positions | 0 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 69.42 mm |
Total shares | 6.18 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Neem | 2.48 mm | $32.22 mm |
Schultze Special Purpose Acquisition Sponsor | 2.25 mm | $922.00 k |
Walleye Capital | 497.52 k | $16.92 mm |
Skaana Management | 290.05 k | $9.86 mm |
Davidson Kempner Capital Management | 283.53 k | $5.67 mm |
Kyle Detwiler | 236.24 k | $60.00 k |
Castle Creek Arbitrage | 84.33 k | $2.24 mm |
Warberg Asset Management | 22.71 k | $749.00 k |
PEAK6 Investments | 22.20 k | $755.00 k |
VIRT Virtu Financial | 10.64 k | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Mar 24 | Henry R Hague III | Common shares | Sell | Dispose S | No | No | 3.3108 | 170 | 562.84 | 11,951 |
27 Feb 24 | Henry R Hague III | Common shares | Sell | Dispose S | No | No | 3.95 | 411 | 1.62 k | 12,121 |
19 Jan 24 | Andres Fajardo | Common shares | Sell | Dispose S | No | No | 2.884 | 1,561 | 4.50 k | 21,795 |
19 Jan 24 | Julian Wilches | Common shares | Sell | Dispose S | No | No | 2.884 | 131 | 377.80 | 7,408 |
20 Dec 23 | Andres Fajardo | Common shares | Sell | Dispose S | No | No | 2.0367 | 177 | 360.50 | 705,819 |
News
Clever Leaves Announces Voluntary Delisting Of Common Shares And SEC Deregistration
26 Apr 24
Cannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense Reductions
1 Apr 24
Clever Leaves Holdings Q4 EPS $(2.95), Sales $4.64M Miss $5.80M Estimate
1 Apr 24
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why
14 Mar 24
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
14 Feb 24